Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2005
08/10/2005CN1213748C Composition containing unionized surfactant and active component and application thereof
08/10/2005CN1213747C Specific therapeutic composition for treating AIDS
08/10/2005CN1213746C Immunopotentiatory agents and physiologically acceptable salts thereof
08/10/2005CN1213733C Method of preparing stable suspension of insoluble microparticles
08/09/2005US6927291 Method for the synthesis of 2′,3′-dideoxy-2′,3′-didehydronucleosides
08/09/2005US6927234 possessing anti-cancer activity, anti-inflammatory activity, anti-obesity activity, and/or hair growth promotion activity
08/09/2005US6927232 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
08/09/2005US6927229 Difluorothioacetamides of oxazolidinones as antibacterial agents
08/09/2005US6927222 Compounds
08/09/2005US6927219 Secondary amides such as N-Adamantan-1-methyl-2-chloro-5-(3,5-dioxo-4,5-dihydro-3H- (1,2,4)triazin-2-yl)-benzamide used as antagonists for biological receptors; antiinflammatiory, anticarcinogenic or antiischemic agents
08/09/2005US6927217 HIV protease inhibitors
08/09/2005US6927208 for the treatment and prevention of AIDS
08/09/2005US6926899 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test
08/09/2005US6926898 Albumin fusion proteins
08/09/2005US6926893 Multi-stage cascade boosting vaccine
08/09/2005US6926763 Gramnegative, grampositive bacteria infections
08/09/2005US6926408 Continuous two-dimensional corneal topography target
08/09/2005CA2310627C Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
08/09/2005CA2258217C Substituted cyclopentane compounds useful as neuraminidase inhibitors
08/09/2005CA2231700C Prodrugs of aspartyl protease inhibitors
08/09/2005CA2150346C Anti-feline herpes virus-1 recombinant antibody and gene fragment coding for said antibody
08/09/2005CA2135278C Peptide for stimulation of cytotoxic t lymphocytes specific for hepatitis c virus
08/09/2005CA2109098C Activity-dependent neurotrophic factor
08/06/2005CA2553946A1 Antibodies against clostridium difficile toxins and uses thereof
08/04/2005WO2005070441A1 Onion extracts
08/04/2005WO2005070421A1 Fluconazole-tinidazole combination for the treatment of vaginal infections, composition thereof and preparation and use of same
08/04/2005WO2005070415A1 Adjuvant compositions
08/04/2005WO2005069771A2 Small molecule antagonists of bcl-2 family proteins
08/04/2005WO2005069717A2 The use os anti-rh antibodies for treating acute thrombocytopenia associated with dengue hemorrhagic fever, hepatitis c and other microbial infections
08/04/2005WO2004007457A3 Substituted benzylamine derivatives and methods of use
08/04/2005US20050171354 Heterocyclic amines such as (2S,3S)-3-((1R)-6-methoxy-1-methyl -1-trifluoromethylisochroman-7-yl)methylamino-2-phenyl piperidine, used as analgesics, antiinflammatory agents, or for prophylaxis of cardiovascular disorders
08/04/2005US20050171353 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5)
08/04/2005US20050171346 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections
08/04/2005US20050171335 Novel antimicrobial peptide and use thereof
08/04/2005US20050171211 vanillylalkyl-(methyl)oxyalkyl-carbonyl derivatives; tyrosinase inhibitor; antioxidant; foods, drugs, cosmetics; reduce lipid peroxide via oxidation; prevent speckles and spots; less toxicity
08/04/2005US20050171183 Indole-type inhibitors of p38 kinase
08/04/2005US20050171176 Pharmaceutically active aromatic guanylhydrazones
08/04/2005US20050171175 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
08/04/2005US20050171174 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/04/2005US20050171173 Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
08/04/2005US20050171158 1-(sulfonylaminomethylcarbonyl)-4-cyclohexylpiperidine compounds such as N-[1-(R)-(4-chlorobenzyl)-2-(4-cyclohexyl-4-[1,2,4]triazol-1-ylmethyl-piperidin-1-yl)-2-oxo-ethyl]-methanesulfonamide; various diseases and disorders such as weight control, eating disorders
08/04/2005US20050171133 Therapeutic compounds
08/04/2005US20050171127 Epzicom; coated tablet formulated with Ceolus" microcrystalline cellulose for once daily administration; synergistic HIV treatment
08/04/2005US20050171125 Novel alkoxypyridine-derivatives
08/04/2005US20050171111 E.g., 4-[[5-[[4-(3-chlorophenyl)-1,2-dihydro-2-oxo-6-quinolinyl]hydroxymethyl]-1H-imidazol-1-yl]methyl]-benzonitrile; prevents the membrane attachment of p21ras and blocks the aberrant growth of ras-transformed tumors
08/04/2005US20050171104 Novel thyroid receptor ligands
08/04/2005US20050171101 Neurodegenerative diseases; diseases ascribed by NMDA- and NO-induced neurotoxicity ; ischemia; antiinflammatory; anticancer; antidiabetic; 2-{3-[4-Phenyl-3,6-dihydro-1(2H)-pyridyl]propyl}-6(5H)-phenanthridinone
08/04/2005US20050171096 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
08/04/2005US20050171092 Chemical compounds
08/04/2005US20050171083 Modified release pharmaceutical formulation
08/04/2005US20050171070 Stable salts of o-acetylsalicylic acid containing basic amino acids II
08/04/2005US20050171068 Novel 4-dedimethylaminotetracycline derivatives
08/04/2005US20050171047 Immunostimulatory nucleic acid molecules
08/04/2005US20050171022 Proteaseome inhibitors for the treatment of herpesviridae infected individuals
08/04/2005US20050170504 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins
08/04/2005US20050170384 Expression vector comprising nucleotide sequences coding protein with sequence similarities to chordin proteins for use as tool in identifying modulator for treatment and prevention of infection and metabolic disorders
08/04/2005US20050170355 Mixture of a nucleic acid and a chitosan with branching groups attached to the amino group, selected from alkyl groups with 2 or more carbon atoms, monosaccharides, oligosaccharides or polysaccharides; gene therapy, genetic vaccines, antisense therapy, anticarcinogenic agents, autoimmune diseases
08/04/2005US20050170348 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
08/04/2005US20050169993 Sustained-release formulation
08/04/2005US20050169983 Chewable soft capsule
08/04/2005US20050169971 Pellet or tablet attractive to livestock masking a drug such as benazepril; animal feed substrate, intimately mixed with coated particles of a carrier material and an active ingredient casing that is coated by a masking protective layer
08/04/2005US20050169943 Isolating outer membrane preparation, immunogenic component or extract from commensal Neisseria and formulating
08/04/2005US20050169937 Attacking immune tolerant species; having at least one consensus amino acid sequence
08/04/2005US20050169918 selectively targeting; screening an effect of a Chemokine receptor (CCR4) modulating agent; adjusting the adhesion of T cells to endothelial cells; treating inflammatory skin disease; side effect reduction without affecting on other cells
08/04/2005US20050169913 Administering a monoclonal antibody or enzyme inhibitor of prothrombinase; therapeutic treatment of bacterial and viral infections, allograft and xenograft rejection, cancer, glomerulonephritis, gastrointestinal disorders and fetal loss; inhibiting gene expression of prothrombinase
08/04/2005CA2553986A1 Adjuvant compositions
08/04/2005CA2553803A1 Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds
08/04/2005CA2553266A1 Substituted quinolines and their use as mycobacterial inhibitors
08/04/2005CA2552584A1 Pyrimidyl phosphonate antiviral compounds and methods of use
08/04/2005CA2552350A1 Bis-indole pyrroles useful as antimicrobials agents
08/04/2005CA2551644A1 Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of usethereof
08/03/2005EP1559795A2 Neisseria genomic sequences and methods of their use
08/03/2005EP1559780A1 Method of strengthening foreign epitope presentation by mhc class i by inhibiting tap activity
08/03/2005EP1559719A1 Novel macrolide derivatives havaing effect of potentiating antifungal activity
08/03/2005EP1559710A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV, process for their preparation and their use
08/03/2005EP1559709A1 Heterocycle-containing carboxylic acid derivative and drug containing the same
08/03/2005EP1559328A1 Fungal feeds for aquaculture and agriculture
08/03/2005EP1559327A1 Bacterial feeds for aquaculture and agriculture
08/03/2005EP1558650A2 Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders
08/03/2005EP1558647A2 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
08/03/2005EP1558646A2 Single domain antibodies directed against interferon- gamma and uses thereof
08/03/2005EP1558645A2 Stabilized single domain antibodies
08/03/2005EP1558633A1 COMPOSITION FOR THE TREATMENT OF INFECTION BY i FLAVIVIRIDAE /i VIRUSES
08/03/2005EP1558628A1 Antigenic peptides
08/03/2005EP1558625A2 4''-modified erythromycin derivatives
08/03/2005EP1558616A2 Meso-substituted porphyrins
08/03/2005EP1558611A2 Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use
08/03/2005EP1558580A2 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
08/03/2005EP1558579A1 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials
08/03/2005EP1558341A2 Transcription factor modulating compounds and methods of use thereof
08/03/2005EP1558276A2 Flaviviris fusion inhibitors
08/03/2005EP1558258A1 Use of piperazine sulfonic acid derivatives as ccr1 antagonists for the treatment of fibrosis, alzheimer disease and other disorders
08/03/2005EP1558236A1 Lysine mixture and apparatus and method for administering lysine
08/03/2005EP1450823A4 Biocidal mixture of 2-propenal-releasing polymer and isothiazolones
08/03/2005EP1399458B1 An arylation method for the functionalization of o-allyl erythromycin derivatives
08/03/2005EP1399446B1 2,6,9-substituted purine derivatives and their use in the treatment of proliferative disorders
08/03/2005EP1368050A4 Virus derived antimicrobial peptides
08/03/2005EP1359975A4 Ocular iontophoretic device and method of use
08/03/2005EP1330455B1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same
08/03/2005EP1330166B1 Food grade transglutaminase inhibitor and uses thereof
1 ... 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 ... 1798